Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Scientific Reports|October 4, 2017
Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammationTom Houben, Yvonne Oligschlaeger, Albert V Bitorina, et al.
JHEP Reports : Innovation in Hepatology|March 24, 2025
Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgeryJonas Santol, Dragana Rajcic, Gregor Ortmayr, et al.
Atherosclerosis|November 7, 2016
Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr<sup>-/-</sup> miceMike L J Jeurissen, Sofie M A Walenbergh, Tom Houben, et al.
Scientific Reports|June 16, 2017
Cathepsin D regulates lipid metabolism in murine steatohepatitisTom Houben, Yvonne Oligschlaeger, Tim Hendrikx, et al.
Plos One|November 30, 2016
Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- MiceMike L J Jeurissen, Sofie M A Walenbergh, Tom Houben, et al.
International Journal of Molecular Sciences|September 26, 2015
Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout MiceSofie M A Walenbergh, Tom Houben, Tim Hendrikx, et al.
Journal of Hepatology|October 5, 2014
Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) miceTim Hendrikx, Mike L J Jeurissen, Veerle Bieghs, et al.
Atherosclerosis|May 23, 2026
Bridging discovery and clinical science: A framework for advancing atherosclerosis research using innovative modelsKaloyan Takov, Marie A C Depuydt, Christophe A T Stevens, et al.
The FEBS Journal|March 31, 2015
Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) miceTim Hendrikx, Mike L J Jeurissen, Patrick J van Gorp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2025
IgM Antibodies Targeting Malondialdehyde Promote Complement-Mediated Liver Injury in Alcohol-Related Liver DiseaseDragana Rajcic, Beatriz Pereira da Silva, Taras Baranovskyi, et al.
Pageof 5